Regenxbio Correlations

RGNX Stock  USD 7.37  0.22  3.08%   
The current 90-days correlation between Regenxbio and Replimune Group is 0.14 (i.e., Average diversification). The correlation of Regenxbio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Regenxbio Correlation With Market

Average diversification

The correlation between Regenxbio and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regenxbio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Moving together with Regenxbio Stock

  0.86DNLI Denali TherapeuticsPairCorr
  0.82DOMH Dominari HoldingsPairCorr
  0.77DTIL Precision BioSciencesPairCorr
  0.73VIGL Vigil NeurosciencePairCorr
  0.66VINC Vincerx PharmaPairCorr
  0.68VKTX Viking TherapeuticsPairCorr
  0.66VNDA Vanda PharmaceuticalsPairCorr
  0.76VRDN Viridian Therapeutics Buyout TrendPairCorr
  0.62VRPX Virpax PharmaceuticalsPairCorr
  0.86VRTX Vertex PharmaceuticalsPairCorr

Moving against Regenxbio Stock

  0.76DRTS Alpha Tau MedicalPairCorr
  0.7CDIOW Cardio DiagnosticsPairCorr
  0.62DMAC DiaMedica TherapeuticsPairCorr
  0.53SABSW SAB BiotherapeuticsPairCorr
  0.41VCEL Vericel Corp OrdPairCorr
  0.39VCYT Veracyte Potential GrowthPairCorr
  0.74VRNA Verona Pharma PLCPairCorr
  0.63SRZNW Surrozen WarrantPairCorr
  0.57DYAI Dyadic InternationalPairCorr
  0.41VSTM VerastemPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RCKTDAWN
PTGXRCKT
IMCRRNA
RNADAWN
RNARCKT
PTGXDAWN
  
High negative correlations   
QURERNA
IMCRQURE
RVMDQURE
QURERCKT
QUREDAWN
PTGXQURE

Risk-Adjusted Indicators

There is a big difference between Regenxbio Stock performing well and Regenxbio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Regenxbio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DAWN  1.84 (0.20) 0.00 (0.18) 0.00 
 3.92 
 11.05 
REPL  3.04  0.02  0.01  0.04  3.44 
 5.66 
 46.30 
MIRM  1.75  0.26  0.11  0.44  2.05 
 5.04 
 12.25 
RCKT  2.53 (0.71) 0.00 (1.49) 0.00 
 4.31 
 16.64 
RNA  2.83 (0.66) 0.00 (1.34) 0.00 
 4.80 
 27.94 
QURE  6.22  2.09  0.40  5.51  4.39 
 14.72 
 122.59 
PTGX  2.12 (0.33) 0.00 (0.53) 0.00 
 3.70 
 16.19 
PLRX  3.11 (0.25) 0.00 (0.36) 0.00 
 5.37 
 20.55 
IMCR  1.83 (0.15) 0.00 (0.22) 0.00 
 3.18 
 10.73 
RVMD  2.07 (0.28) 0.00 (0.51) 0.00 
 4.11 
 16.40 

Regenxbio Corporate Management

Ram PharmDExecutive OperationsProfile
JD IIExecutive OfficerProfile
Tricia TruehartVP CommunicationsProfile
Olivier DanosChief Scientific OfficerProfile